Insider Selling: Diagnos Inc (ADK) Insider Sells 2,026,000 Shares of Stock

Diagnos Inc (CVE:ADK) insider Corporation Dundee sold 2,026,000 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of C$0.09, for a total value of C$182,340.00.

Diagnos Inc (CVE:ADK) remained flat at $C$0.09 during mid-day trading on Friday. The company had a trading volume of 219,111 shares, compared to its average volume of 1,151,705. Diagnos Inc has a twelve month low of C$0.08 and a twelve month high of C$0.20. The firm has a market capitalization of $15.52, a P/E ratio of -4.50 and a beta of 1.24.

TRADEMARK VIOLATION WARNING: “Insider Selling: Diagnos Inc (ADK) Insider Sells 2,026,000 Shares of Stock” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://sportsperspectives.com/2018/02/09/insider-selling-diagnos-inc-adk-insider-sells-2026000-shares-of-stock.html.

Diagnos Company Profile

DIAGNOS Inc provides data mining and interpretation services, and designs data analytics software products in Canada, the United Arab Emirates, the United States, Kenya, Nigeria, Turkey, Malaysia, Switzerland, and Colombia. It operates through Healthcare and Natural Resources segments. The Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis, a software tool, which assists health specialists in the detection of diabetic retinopathy.

Receive News & Ratings for Diagnos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diagnos and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply